These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Erbium:YAG laser deep sclerectomy: an alternative approach to glaucoma surgery.
    Author: Pallikaris IG, Kozobolis VP, Christodoulakis EV.
    Journal: Ophthalmic Surg Lasers Imaging; 2003; 34(5):375-80. PubMed ID: 14509460.
    Abstract:
    BACKGROUND AND OBJECTIVES: To study and evaluate, prospectively, the effectiveness and the safety of deep sclerectomy when it is performed with the assistance of the erbium:YAG laser in eyes with primary open-angle glaucoma. PATIENTS AND METHODS: Forty eyes of 40 patients with primary open-angle glaucoma or pseudoexfoliative glaucoma were enrolled consecutively to undergo laser deep sclerectomy. Mitomycin C (0.2 mg/mL for 2.5 minutes) was also used before the superficial scleral flap formation. The follow-up was 24 months for all patients. RESULTS: The intraocular pressure was significantly decreased by 9.15 mm Hg or 35.1% (from 26.05 +/- 2.55 to 16.9 +/- 3.45 mm Hg) at the end of the follow-up period. The complete and qualified success rates at the end of the follow-up period were 37.5% and 62.5%, respectively. Mild complications such as choroidal detachment, hyphema, and leakage were observed. CONCLUSIONS: The use of the erbium:YAG laser for performing a deep sclerectomy procedure seems to be a safe and relatively effective alternative to the conventional surgical procedure. Further studies and longer follow-up are necessary for the evaluation of the efficacy of this technique.
    [Abstract] [Full Text] [Related] [New Search]